Gamaleya applies for use of its single-dose COVID-19 vaccine in PH

enablePagination: false
maxItemsPerPage: 10
totalITemsFound:
maxPaginationLinks: 10
maxPossiblePages:
startIndex:
endIndex:

FILE PHOTO

Metro Manila (CNN Philippines, August 10) — The Food and Drug Administration said Russian vaccine maker Gamaleya has applied for emergency use of its single-dose COVID-19 vaccine in the country.

“Iyong Sputnik Light, ito po iyong single-dose na Sputnik na nag-apply na rin po actually dito sa atin ng EUA at pinagaaralan na rin po ng ating vaccine experts,” FDA Director General Eric Domingo revealed during a televised Cabinet meeting on Monday.

[Translation: Sputnik Light, this is the single-dose vaccine of Spuntik that already applied for EUA here in the country and our vaccine experts are already studying this.]

The Russian Direct Investment Fund announced in May that Sputnik Light has been authorized for use in their country.

The coronavirus shot is based on a human adenoviral vector platform and has a storage requirement of 2 to 8 degrees Celsius. The RDIF said it has 79.4% efficacy.

“Sputnik Light has proven effective against all new strains of coronavirus, as demonstrated by the Gamaleya Center during laboratory tests,” it added.

So far in the Philippines, the only approved single-dose COVID-19 vaccine is Johnson & Johnson's Janssen vaccine.

More than 3.2 million doses of the American-made vaccine arrived in the country last month, which were donated by the United States through the global initiative COVAX facility.